Cyclization of Peptides by using Selenolanthionine Bridges

被引：36

作者：

de Araujo, Aline Dantas ^{[1
]}

Mobli, Mehdi ^{[1
]}

King, Glenn F. ^{[1
]}

Alewood, Paul F. ^{[1
]}

机构：

[1] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2012年 / 51卷 / 41期

关键词：

lanthionines; peptides; peptide cyclization; selenium; selenocysteine; BIOLOGICAL-ACTIVITIES; SOLID-PHASE; ANALOGS; POTENT; LANTIBIOTICS; DEPROTECTION;

D O I：

10.1002/anie.201204229

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Selenocysteine does the job: Lanthionine bridges are important structural elements in naturally occurring lantibiotics. They can be engineered into peptides to increase biological activity and metabolic stability. Macrocyclization of peptides by intramolecular thiolation of cysteine is often difficult but can be achieved by replacing cysteine with the more reactive isosteric selenocysteine amino acid. Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

引用

页码：10298 / 10302

页数：5

共 45 条

[1]

[Anonymous], 2011, ANGEW CHEM, DOI DOI 10.1002/ANGE.201104169

[2]

[Anonymous], 2009, DRUG DISCOV TODAY

[3] α-selenoconotoxins, a new class of potent α7 neuronal nicotinic receptor antagonists [J].

Armishaw, Christopher J. ;

Daly, Norelle L. ;

Nevin, Simon T. ;

Adams, David J. ;

Craik, David J. ;

Alewood, Paul F. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (20) :14136-14143

[4] Lantibiotics: Mode of Action, Biosynthesis and Bioengineering [J].

Bierbaum, G. ;

Sahl, H. -G. .

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2009, 10 (01) :2-18

[5]

de Araujo A. D., 2011, ANGEW CHEM, V123, P6657, DOI DOI 10.1002/ANGE.201101642

[6] Total Synthesis of the Analgesic Conotoxin MrVIB through Selenocysteine-Assisted Folding [J].

de Araujo, Aline Dantas ;

Callaghan, Brid ;

Nevin, Simon T. ;

Daly, Norelle L. ;

Craik, David J. ;

Moretta, Melissa ;

Hopping, Gene ;

Christie, Macdonald J. ;

Adams, David J. ;

Alewood, Paul F. .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (29) :6527-6529

[7]

Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]

[8] Studies on deprotection of cysteine and selenocysteine side-chain protecting groups [J].

Harris, Katharine M. ;

Flemer, Stevenson, Jr. ;

Hondal, Robert J. .

JOURNAL OF PEPTIDE SCIENCE, 2007, 13 (02) :81-93

[9] Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog [J].

Kluskens, Leon D. ;

Nelemans, S. Adriaan ;

Rink, Rick ;

de Vries, Louwe ;

Meter-Arkema, Anita ;

Wang, Yong ;

Walther, Thomas ;

Kuipers, Anneke ;

Moll, Gert N. ;

Haas, Marijke .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03) :849-854

[10]

Knerr P.J., 2012, ANNU REV BIOCHEM, DOI [10.1146/annurev-biochem-060110-113521, DOI 10.1146/ANNUREV-BIOCHEM-060110-113521]

← 1 2 3 4 5 →